Gibiansky, E., Gibiansky, L., Carlile, D. J., Jamois, C., Buchheit, V., & Frey, N. (2014). Population Pharmacokinetics of Obinutuzumab (GA101) in Chronic Lymphocytic Leukemia (CLL) and Non-Hodgkin's Lymphoma and Exposure–Response in CLL. CPT Pharmacometrics Syst Pharmacol.
Citación estilo ChicagoGibiansky, E., L. Gibiansky, D J. Carlile, C. Jamois, V. Buchheit, and N. Frey. "Population Pharmacokinetics of Obinutuzumab (GA101) in Chronic Lymphocytic Leukemia (CLL) and Non-Hodgkin's Lymphoma and Exposure–Response in CLL." CPT Pharmacometrics Syst Pharmacol 2014.
Cita MLAGibiansky, E., et al. "Population Pharmacokinetics of Obinutuzumab (GA101) in Chronic Lymphocytic Leukemia (CLL) and Non-Hodgkin's Lymphoma and Exposure–Response in CLL." CPT Pharmacometrics Syst Pharmacol 2014.